
Esperion Therapeutics competitors include Biogen and MyoKardia. Esperion Therapeutics ranks 2nd in CEO Score on Comparably vs its competitors. See below how Esperion Therapeutics compares to its competitors with CEO Rankings, Overall Culture Score, eNPS, Gender and Diversity Scores.


16 Employees at Esperion Therapeutics rate Timothy Mayleben a 21 out of 100, which ranks them 2nd below Biogen's CEO,Michel Vounatsos. Last rating was months ago.
19 Employees rate Esperion Therapeutics' Overall Culture a 30/100, which ranks it 2nd against its competitors, below Biogen. Overall Culture scores are aggregated from all of the questions employees at a company answer on Comparably.
16 Employees rate Esperion Therapeutics' Employee Net Promoter Score a -87, which ranks it 2nd against its competitors, below Biogen. Employee Net Promoter score tracks employees' overall score to this question - “On a scale from 0-10, how likely are you to recommend working at Esperion Therapeutics to a friend?”.
8 Employees rate Esperion Therapeutics' Gender Score a 30/100, which ranks it 2nd against its competitors, below Biogen. The Gender Score tracks how positively women rate their experience at Esperion Therapeutics.
5 Employees rate Esperion Therapeutics' Diversity Score a 23/100, which ranks it 2nd against its competitors, below Biogen. The Diversity Score tracks how positively diverse employees rate their experience at Esperion Therapeutics.
